Endocrine Society GUIDELINES Bundle (free trial)

Paget's Disease of Bone

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: http://eguideline.guidelinecentral.com/i/1140175

Contents of this Issue

Navigation

Page 1 of 5

Key Points Î Paget's disease of bone (osteitis deformans) is a chronic benign disorder of bone that generally affects one or several bones. Î The abnormal bone structure may be associated with enlarged affected bones and skeletal deformity, particularly in weight-bearing bones. Î Many patients with Paget's disease of bone are asymptomatic. Bone pain, mild to moderate in intensity and described as deep and aching, is a feature of Paget's disease of bone, usually developing late rather than early in the disease process, and it is only present in a minority of patients. Î The clinical features and complications of Paget's disease are closely related, but presentation varies from patient to patient. Î The most common neurological complication of Paget's disease is hearing loss associated with disease involving the skull. Î Studies of patients with Paget's disease indicate there is a family history of the disorder, an autosomal dominant transmission pattern, in 5%–40%, with most researchers reporting a 10%–20% incidence. Î Paget's disease affects both men and women, with an apparent small male predominance. It rarely manifests itself clinically before age 40, and the frequency of the condition increases with advancing age. Î Rates in the United States are estimated to be approximately 2%–3% among individuals older than 55 years. Diagnosis Imaging Î In patients with suspected Paget's disease, the Endocrine Society (ES) recommends obtaining plain radiographs of the suspicious regions of the skeleton. (1|⊕⊕⊕⊕) Î In patients diagnosed with Paget's disease, the ES suggests a radionuclide bone scan to determine the extent of the disease and identify possible asymptomatic sites. (2|⊕⊕⊕ ) Biochemistry Î The ES recommends that after radiological diagnosis of Paget's disease, the initial biochemical evaluation of a patient should be done using serum total alkaline phosphatase (ALP) or with the use of a more specific marker of bone formation when appropriate. (1|⊕⊕⊕⊕)

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Paget's Disease of Bone